This analysis demonstrated hsa04512:Extracellular matrix (ECM)-receptor interaction, hsa04510:focal adhesion, hsa05410:hypertrophic cardiomyopathy (HCM), hsa03320:PPAR signaling pathway, hsa04350:TGF-beta signaling pathway, hsa05412:arrhythmogenic right ventricular cardiomyopathy (ARVC), hsa05414:dilated cardiomyopathy, hsa05219:bladder cancer, hsa04115:p53 signaling pathway, hsa04514:cell adhesion molecules (CAMs), hsa04614:renin-angiotensin system, and hsa05200:pathways in cancer (Table 2) were all statistically significant (p<0.05). This evidence concerns the gene TP53 and arrhythmogenic right ventricular cardiomyopathy.